Yang J, Zhao M, Zhou X, Yan M, Zhao X, Li F. Cost-Effectiveness of Sorafenib, Lenvatinib, and FOLFOX4 for Advanced Hepatocellular Carcinoma in China. J Health Sci Med Res [internet]. 2025 Jun. 19 [cited 2026 Sep. 29];43(4):e20251153. available from: https://he01.tci-thaijo.org/index.php/jhsmr/article/view/280260